Page last updated: 2024-08-24

plerixafor and wp1066

plerixafor has been researched along with wp1066 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jin, YB; Jung, JE; Jung, MJ; Kim, YM; Ko, YG; Lee, JC; Lee, JS; Lee, SJ; Park, MJ; Rho, JK1

Other Studies

1 other study(ies) available for plerixafor and wp1066

ArticleYear
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
    Oncogene, 2013, Jan-10, Volume: 32, Issue:2

    Topics: Animals; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Drug Resistance, Neoplasm; Female; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Tyrphostins; Up-Regulation

2013